Agnieszka Potęga

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Pharmacological reports : PR

Molecules (Basel, Switzerland)

Pharmaceutics

Pharmaceuticals (Basel, Switzerland)

Gdańsk University of Technology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Gdańsk University of Technology May 09 2012

Poland

PhD; position: assistant professor :: Department of Pharmaceutical Technology and Biochemistry

Publications

Joanna Pilch, Agnieszka Potęga, Patrycja Kowalik, Agata Kowalczyk, Piotr Bujak, Artur Kasprzak, Ewa Paluszkiewicz, Anna Maria Nowicka
In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot-β-cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers. Pharmacological reports : PR 76 (4) (2024)
Joanna Pilch, Agnieszka Potęga, Patrycja Kowalik, Agata Kowalczyk, Piotr Bujak, Artur Kasprzak, Ewa Paluszkiewicz, Anna Maria Nowicka
In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot-β-cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers. Pharmacological reports : PR (2024)
Joanna Pilch, Agnieszka Potęga, Patrycja Kowalik, Agata Kowalczyk, Piotr Bujak, Artur Kasprzak, Ewa Paluszkiewicz, Anna Maria Nowicka
In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot-β-cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers. Pharmacological reports : PR 76 (4) (2024)
Joanna Pilch, Agnieszka Potęga, Patrycja Kowalik, Agata Kowalczyk, Piotr Bujak, Artur Kasprzak, Ewa Paluszkiewicz, Anna Maria Nowicka
In vitro biological evaluation of a novel folic acid-targeted receptor quantum dot-β-cyclodextrin carrier for C-2028 unsymmetrical bisacridine in the treatment of human lung and prostate cancers. Pharmacological reports : PR 76 (4) (2024)
Agnieszka Potęga, Dominika Rafalska, Dawid Kazimierczyk, Michał Kosno, Aleksandra Pawłowicz, Witold Andrałojć, Ewa Paluszkiewicz, Tomasz Laskowski
In Vitro Enzyme Kinetics and NMR-Based Product Elucidation for Glutathione S-Conjugation of the Anticancer Unsymmetrical Bisacridine C-2028 in Liver Microsomes and Cytosol: Major Role of Glutathione S-Transferase M1-1 Isoenzyme. Molecules (Basel, Switzerland) 28 (19) (2023)
Joanna Pilch, Agnieszka Potęga, Agata Kowalczyk, Artur Kasprzak, Patrycja Kowalik, Piotr Bujak, Ewa Paluszkiewicz, Ewa Augustin, Anna Maria Nowicka
pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy. Pharmaceutics 15 (1) (2023)
Joanna Pilch, Agnieszka Potęga, Agata Kowalczyk, Artur Kasprzak, Patrycja Kowalik, Piotr Bujak, Ewa Paluszkiewicz, Ewa Augustin, Anna Maria Nowicka
pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy. Pharmaceutics 15 (1) (2023)
Joanna Pilch, Agnieszka Potęga, Agata Kowalczyk, Artur Kasprzak, Patrycja Kowalik, Piotr Bujak, Ewa Paluszkiewicz, Ewa Augustin, Anna Maria Nowicka
pH-Responsive Drug Delivery Nanoplatforms as Smart Carriers of Unsymmetrical Bisacridines for Targeted Cancer Therapy. Pharmaceutics 15 (1) (2023)
Agnieszka Potęga
Glutathione-Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation. Molecules (Basel, Switzerland) 27 (16) (2022)
Michał Kosno, Tomasz Laskowski, Joanna E Frackowiak, Agnieszka Potęga, Agnieszka Kurdyn, Witold Andrałojć, Julia Borzyszkowska-Bukowska, Katarzyna Szwarc-Karabyka, Zofia Mazerska
Acid-Base Equilibrium and Self-Association in Relation to High Antitumor Activity of Selected Unsymmetrical Bisacridines Established by Extensive Chemometric Analysis. Molecules (Basel, Switzerland) 27 (13) (2022)
Anna Mieszkowska, Anna Maria Nowicka, Agata Kowalczyk, Agnieszka Potęga, Monika Pawłowska, Michał Kosno, Ewa Augustin, Zofia Mazerska
Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Agnieszka Potęga, Dorota Garwolińska, Anna M Nowicka, Michał Fau, Agata Kot-Wasik, Zofia Mazerska
Phase I and phase II metabolism simulation of antitumor-active 2-hydroxyacridinone with electrochemistry coupled on-line with mass spectrometry. Xenobiotica; the fate of foreign compounds in biological systems 49 (8) (2019)

Agnieszka Potęga.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Agnieszka Potęga